Australia approves the world's first transgenic banana

Published Feb 22, 2024

Tridge summary

The world's first genetically modified banana, QCAV-4, has been approved for human consumption by Food Standards Australia New Zealand (FSANZ). The banana, developed by Professor James Dale's team at the Queensland University of Technology, is resistant to the Panama Disease, a fungus that poses a significant threat to the global banana industry. The Food Ministers Meeting (FMM) now has 60 days to either ratify the decision or request a review. The QCAV-4 banana has undergone over seven years of field trials, showing high resistance to the disease.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

Food Standards Australia New Zealand (FSANZ), the Australian and New Zealand regulatory agency, today announced to the Food Ministers Meeting (FMM) that it has given approval to the "QCAV-4" biotechnology event for bananas as safe for human consumption. Now, the FMM, made up of ministers from Australia's state and territory governments, as well as the governments of Australia and New Zealand, has a deadline of 60 days to ratify the FSANZ decision or request a review. The QCAV-4 banana marks a notable breakthrough as the world's first genetically modified banana to gain approval for commercial production. Furthermore, it is the first genetically modified Australian fruit approved for cultivation in the country. This banana variety has the potential to provide a safety net against the devastating tropical fungus race 4 responsible for Panama Disease (TR4), a serious threat to the $20 billion global banana industry. Professor James Dale, a renowned researcher at the Queensland ...

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.